KW-2149-induced pulmonary toxicity is not prevented by corticosteroids: a phase I and pharmacokinetic study von Schrijvers, D, Catimel, G, Highley, M, Höppener, FJP, Dirix, L, Bruijn, E De, Droz, J P, Oosterom, AT Van

Volltext

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin von DE JONG, R. S, MULDER, N. H, UGES, D. R. A, SLEIJFER, D. T, HÖPPENER, F. J. P, GROEN, H. J. M, WILLEMSE, P. H. B, VAN DER GRAAF, W. T. A, DE VRIES, E. G. E

Volltext